VEGFA and age-related macular degeneration: Dilution also occurs in AMD treatment, when an anti-VEGF antibody is administered at 50 μl of a 10-40 mg/ml solution (0.5 mg) into the viscous vitreous humor of the eye – which is generally around 4 ml.